Octapharma to present new clinical data and studies at ASH 2022 to demonstrate its continued mission to meet the challenges faced by people with bleeding disorders
/PRNewswire/ -- New clinical data from Octapharma's haematology portfolio, including the results of the phase 3 WIL-31 study, will be presented during the...
Source: prnewswire.com